HIF1A and breast cancer: The data indicate that the bioactive SFN combined with AZ decreased intra-tumor hypoxia and the subsequent expression of HIF-1α and the downstream effector CAIX involved in in decreasing the level of intra-tumor hypoxia and the downstream effector CAIX involved in low oxygen BC xenografts.